Does TOFACITINIB Cause Post procedural complication? 135 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Post procedural complication have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
135
Reports of Post procedural complication with TOFACITINIB
0.1%
of all TOFACITINIB reports
8
Deaths
56
Hospitalizations
How Dangerous Is Post procedural complication From TOFACITINIB?
Of the 135 reports, 8 (5.9%) resulted in death, 56 (41.5%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Post procedural complication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Post procedural complication?
ADALIMUMAB (2,494)
ETANERCEPT (318)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (244)
UPADACITINIB (241)
RISANKIZUMAB-RZAA (232)
INFLIXIMAB (217)
METHOTREXATE (188)
TREPROSTINIL (174)
HUMAN IMMUNOGLOBULIN G (159)
PREDNISONE (157)
Which TOFACITINIB Alternatives Have Lower Post procedural complication Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN